Phase II trial of bisantrene in patients with advanced sarcoma: a Southwest Oncology Group Study.
Cowan
J D
JD
Gehan
E
E
Rivkin
S E
SE
Jones
S E
SE
D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007958:Leukocyte Count; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010976:Platelet Count; D012509:Sarcoma / Q000188:drug therapy*
D000873:Anthracenes; D000970:Antineoplastic Agents; C031404:bisantrene